Pfizer (PFE) Asset Utilization Ratio (2009 - 2026)
Pfizer (PFE) posted quarterly Asset Utilization Ratio of 0.01 for Q1 2026, down 102.83% year-over-year from 0.4 in Q1 2025, and up 23.5% quarter-over-quarter from 0.01 in Q4 2025.
Pfizer (PFE) Asset Utilization Ratio (2009 - 2026) Analysis & Trends
Pfizer (PFE) has reported Asset Utilization Ratio for 18 consecutive years, with 0.01 the latest figure, recorded in Q1 2026.
- In Q1 2026, Asset Utilization Ratio fell 102.83% year-over-year to 0.01; the TTM figure through Mar 2026 stood at 0.01 (down 102.83% YoY), while the FY2025 annual figure was 0.04, up 13.48% from the prior year.
- Asset Utilization Ratio improved to 0.01 in Q1 2026 per PFE's latest filing, from 0.01 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 0.6 in Q3 2022 and bottomed at 0.01 in Q4 2025.
- Historically, Asset Utilization Ratio has averaged 0.28 across 5 years, with a median of 0.33 in 2024.
- Annual changes were most pronounced in 2025 — Asset Utilization Ratio jumped 256.13% — and 2026, when it tumbled 102.83%.
- Pfizer's Asset Utilization Ratio stood at 0.5 in 2022, then slumped by 79.71% to 0.1 in 2023, then surged by 235.62% to 0.34 in 2024, then tumbled by 104.35% to 0.01 in 2025, then increased by 23.5% to 0.01 in 2026.
- Business Quant data shows PFE's Asset Utilization Ratio at 0.01 in Q1 2026, 0.01 in Q4 2025, and 0.38 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.88 Bn | 625.12 Bn | 17.26 Bn | 0.49 |
| 2 | AbbVie | 463.46 Bn | 456.89 Bn | 12.70 Bn | 0.47 |
| 3 | Merck | 367.92 Bn | 360.78 Bn | 12.21 Bn | 0.52 |
| 4 | Novartis Ag | 297.71 Bn | 290.02 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 255.55 Bn | 250.65 Bn | 12.86 Bn | 0.53 |
| 6 | Amgen | 234.52 Bn | 220.53 Bn | 7.24 Bn | 0.40 |
| 7 | Gilead Sciences | 178.22 Bn | 175.04 Bn | 6.22 Bn | 0.58 |
| 8 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | 0.31 |
| 9 | Gsk | 105.32 Bn | 101.15 Bn | 8.24 Bn | 0.64 |
| 10 | Sanofi | 54.20 Bn | 46.82 Bn | 10.79 Bn | 0.36 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 28, 2026 | 0.31 |
| Mar 29, 2026 | -0.01 |
| Dec 31, 2025 | -0.01 |
| Sep 28, 2025 | 0.38 |
| Jun 29, 2025 | 0.35 |
| Mar 30, 2025 | 0.40 |
| Sep 29, 2024 | 0.34 |
| Jun 30, 2024 | 0.15 |
| Mar 31, 2024 | 0.11 |
| Dec 31, 2023 | 0.10 |
| Jul 2, 2023 | 0.18 |
| Apr 2, 2023 | 0.31 |
| Dec 31, 2022 | 0.50 |
| Jul 3, 2022 | 0.60 |
| Apr 3, 2022 | 0.58 |
| Dec 31, 2021 | 0.83 |
| Oct 3, 2021 | 1.12 |
| Jul 4, 2021 | 0.45 |
| Apr 4, 2021 | 0.41 |
| Sep 27, 2020 | 0.56 |